+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The efficacy of low estrogen transdermal therapy in climacteric symptoms management



The efficacy of low estrogen transdermal therapy in climacteric symptoms management



Ginekologia Polska 71(9): 1079-1082



The aim of the study was to evaluate the efficacy and tolerability of low doses estrogen transdermal system treatment in management of climacteric symptoms. On the basis of performed researches it seems to be reasonable to start hormonal replacement therapy with the very low dosage of estrogen to achieve sufficient results and avoid side effects.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 047634438

Download citation: RISBibTeXText

PMID: 11082979


Related references

Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: Influence on climacteric symptoms, body weight and bleeding pattern. Maturitas 28(2): 117-125, 1997

The treatment of climacteric symptoms using vaginal rectal and transdermal estrogen substitution. Gynaekologe 19(4): 248-253, 1986

Efficacy of tibolone and transdermal estrogen therapy on psychological symptoms in women following surgical menopause. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 91(1): 58-62, 2005

A review of transdermal nonpatch estrogen therapy for the management of menopausal symptoms. Journal of Women's Health 19(1): 47-55, 2010

Oral or transdermal estrogen substitution therapy in climacteric?. Geburtshilfe und Frauenheilkunde 54(3): 119-130, 1994

Efficacy of biorhythmic transdermal combined hormone treatment in relieving climacteric symptoms: a pilot study. International Journal of General Medicine 4: 159-163, 2011

An open, randomized assessment of the efficacy and safety of two transdermal estradiol patches for relief of climacteric symptoms. Maturitas 27(Suppl. ): 209, 1997

Efficacy and tolerability of transdermal 17 beta-estradiol in patients with climacteric symptoms: Dose titration according to individual choice. Current Therapeutic Research 57(7): 506-515, 1996

Comparison of the effects of oral and transdermal estradiol administration on estrogen metabolism protein synthesis gonadotropin release bone turnover and climacteric symptoms in postmenopausal women. Clinical Endocrinology 30(3): 241-250, 1989

Efficacy on climacteric symptoms and safety of low dose estradiol transdermal matrix patches. A randomized, double-blind placebo-controlled study. Arzneimittel-Forschung 50(3): 293-300, 2000

Estrogen therapy in psychiatric symptoms associated with climacteric. Lakartidningen 77(9): 785-787, 1980

Effect of estrogen therapy on climacteric symptoms and tissue changes. Acta Obstetricia et Gynecologica Scandinavica 53(3): 267-269, 1974

The combined androgen-estrogen therapy of climacteric deficiency symptoms. Munchener Medizinische Wochenschrift 95(48): 1305-1306, 1953

Symptoms and management of estrogen deficiency in the climacteric and post menopausal years. British Journal of Sexual Medicine 9(82): 23-30, 1982

Climacteric symptoms and estrogen replacement therapy in women with endometrial carcinoma. Acta Obstetricia et Gynecologica Scandinavica 65(1): 81-87, 1986